Associations Among Chronic Obstructive Pulmonary Disease with Asthma, Pneumonia, and Corticosteroid Use in the General Population

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2020 Feb 25

PMID 32092112

Citations 5

Authors

Jun-Jun Yeh

Cheng-Li Lin

Chia-Hung Kao

Affiliations

Soon will be listed here.

Abstract

Purpose: To evaluate the association among chronic obstructive pulmonary disease (COPD) with asthma, steroid use, and pneumonia in the general population.

Methods: Using Taiwan's National Health Insurance Research Database to identify patients with incident pneumonia, we established a COPD with asthma cohort of 12,538 patients and a COPD cohort of 25,069 patients. In both cohorts, the risk of incident pneumonia was assessed using multivariable Cox proportional hazards models.

Results: The adjusted hazard ratio (aHR) with 95% confidence interval (CI) for incident pneumonia was 2.38 (2.14, 2.66) in the COPD with asthma cohort, regardless of age, sex, comorbidities, and drug use. COPD cohort without inhaled corticosteroids (ICSs) use served as a reference. The aHR (95% CI) for COPD cohort with ICSs use was 1.34 (0.98, 1.83); that for COPD with asthma cohort without ICSs use was 2.46 (2.20, 2.76); and that for COPD with asthma cohort with ICSs use was 2.32 (1.99, 2.72). COPD cohort without oral steroids (OSs) use served as a reference; the aHR (95% CI) for COPD with asthma cohort without OSs use and with OSs use was 3.25 (2.72, 3.89) and 2.38 (2.07, 2.74), respectively.

Conclusions: The COPD with asthma cohort had a higher risk of incident pneumonia, regardless of age, sex, comorbidities, and ICSs or OSs use. COPD cohort with ICSs use did not have a notable risk of incident pneumonia. The COPD with asthma cohort had a higher risk of incident pneumonia, even without ICSs/OSs use.

Citing Articles

Asthma Therapies on Pulmonary Tuberculosis Pneumonia in Predominant Bronchiectasis-Asthma Combination.

Yeh J, Lin H, Yang Y, Hsu C, Kao C Front Pharmacol. 2022; 13:790031.

PMID: 35431916 PMC: 9006509. DOI: 10.3389/fphar.2022.790031.

Time-dependent propensity-matched general population study of the effects of statin use on cancer risk in an interstitial lung disease and pulmonary fibrosis cohort.

Yeh J, Lai J, Lin C, Hsu C, Kao C BMJ Open. 2021; 11(10):e047039.

PMID: 34635513 PMC: 8506875. DOI: 10.1136/bmjopen-2020-047039.

Systematic review on long-term adverse effects of inhaled corticosteroids in the treatment of COPD.

Miravitlles M, Auladell-Rispau A, Monteagudo M, Vazquez-Niebla J, Mohammed J, Nunez A Eur Respir Rev. 2021; 30(160).

PMID: 34168063 PMC: 9488732. DOI: 10.1183/16000617.0075-2021.

Beneficial Immunomodulatory Effects of Fluticasone Propionate in -Infected Mice.

Paroczai D, Sejben A, Kokai D, Virok D, Endresz V, Burian K Pathogens. 2021; 10(3).

PMID: 33799333 PMC: 8001673. DOI: 10.3390/pathogens10030338.

Decreased Long-Term Respiratory Infection Risk After Bariatric Surgery: a Comprehensive National Cohort Study.

Chen J, Wei Y, Chen C, Su Y, Tsai R, Chin W Obes Surg. 2020; 31(2):499-507.

PMID: 32989625 DOI: 10.1007/s11695-020-05001-5.

References

Christenson S, Steiling K, van den Berge M, Hijazi K, Hiemstra P, Postma D . Asthma-COPD overlap. Clinical relevance of genomic signatures of type 2 inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2015; 191(7):758-66. PMC: 4407484. DOI: 10.1164/rccm.201408-1458OC. View

Su V, Yang K, Yang Y, Tsai Y, Perng D, Su W . Use of ICS/LABA Combinations or LAMA Is Associated with a Lower Risk of Acute Exacerbation in Patients with Coexistent COPD and Asthma. J Allergy Clin Immunol Pract. 2018; 6(6):1927-1935.e3. DOI: 10.1016/j.jaip.2018.01.035. View

Zhao H, Kang C, Rouse M, Patel R, Kita H, Juhn Y . The Role of IL-17 in the Association between Pneumococcal Pneumonia and Allergic Sensitization. Int J Microbiol. 2011; 2011:709509. PMC: 3227511. DOI: 10.1155/2011/709509. View

Leung J, Tiew P, Mac Aogain M, Budden K, Yong V, Thomas S . The role of acute and chronic respiratory colonization and infections in the pathogenesis of COPD. Respirology. 2017; 22(4):634-650. PMC: 7169176. DOI: 10.1111/resp.13032. View

Yeh J, Wang Y, Kao C . Asthma-Chronic Obstructive Pulmonary Diseases Overlap Syndrome Increases the Risk of Incident Tuberculosis: A National Cohort Study. PLoS One. 2016; 11(7):e0159012. PMC: 4957791. DOI: 10.1371/journal.pone.0159012. View

Strange C, Kumbhare S . Reply: Asthma/COPD Overlap Syndrome and Medicare 30-Day Readmissions. Ann Am Thorac Soc. 2016; 13(7):1192. DOI: 10.1513/AnnalsATS.201604-269LE. View

Lee Y, Huang Y, Tsai Y, Huang S, Kuo K, Mckee M . The impact of universal National Health Insurance on population health: the experience of Taiwan. BMC Health Serv Res. 2010; 10:225. PMC: 2924329. DOI: 10.1186/1472-6963-10-225. View

Rovina N, Dima E, Gerassimou C, Kollintza A, Gratziou C, Roussos C . Interleukin-18 in induced sputum: association with lung function in chronic obstructive pulmonary disease. Respir Med. 2009; 103(7):1056-62. DOI: 10.1016/j.rmed.2009.01.011. View

Shantakumar S, Pwu R, Dsilva L, Wurst K, Kuo Y, Yang Y . Burden of asthma and COPD overlap (ACO) in Taiwan: a nationwide population-based study. BMC Pulm Med. 2018; 18(1):16. PMC: 5784537. DOI: 10.1186/s12890-017-0571-7. View

10.

Hung G, Ko K, Lin C, Yen R, Kao C . Impact of initial myocardial perfusion imaging versus invasive coronary angiography on outcomes in coronary artery disease: a nationwide cohort study. Eur J Nucl Med Mol Imaging. 2017; 45(4):567-574. DOI: 10.1007/s00259-017-3872-4. View

11.

Han M . GOLD 2019: a new way forward. Lancet Respir Med. 2018; 7(1):16-17. DOI: 10.1016/S2213-2600(18)30498-3. View

12.

Mindus S, Malinovschi A, Ekerljung L, Forsberg B, Gislason T, Jogi R . Asthma and COPD overlap (ACO) is related to a high burden of sleep disturbance and respiratory symptoms: Results from the RHINE and Swedish GA2LEN surveys. PLoS One. 2018; 13(4):e0195055. PMC: 5880361. DOI: 10.1371/journal.pone.0195055. View

13.

Miyashita N, Kawai Y, Inamura N, Tanaka T, Akaike H, Teranishi H . Setting a standard for the initiation of steroid therapy in refractory or severe Mycoplasma pneumoniae pneumonia in adolescents and adults. J Infect Chemother. 2014; 21(3):153-60. DOI: 10.1016/j.jiac.2014.10.008. View

14.

Waljee A, Rogers M, Lin P, Singal A, Stein J, Marks R . Short term use of oral corticosteroids and related harms among adults in the United States: population based cohort study. BMJ. 2017; 357:j1415. PMC: 6284230. DOI: 10.1136/bmj.j1415. View

15.

Narita M, Tanaka H . Late increase of interleukin-18 levels in blood during Mycoplasma pneumoniae pneumonia. Cytokine. 2012; 59(1):18-9. DOI: 10.1016/j.cyto.2012.04.007. View

16.

Flattet Y, Garin N, Serratrice J, Perrier A, Stirnemann J, Carballo S . Determining prognosis in acute exacerbation of COPD. Int J Chron Obstruct Pulmon Dis. 2017; 12:467-475. PMC: 5293360. DOI: 10.2147/COPD.S122382. View

17.

Lin S, Chen D, Lin C, Lee H, Lin T, Wang I . Risk of acute coronary syndrome in patients with cervical spondylosis. Atherosclerosis. 2018; 271:136-141. DOI: 10.1016/j.atherosclerosis.2018.02.029. View

18.

Yeh J, Wei Y, Lin C, Hsu W . Association of asthma-chronic obstructive pulmonary disease overlap syndrome with coronary artery disease, cardiac dysrhythmia and heart failure: a population-based retrospective cohort study. BMJ Open. 2017; 7(10):e017657. PMC: 5640024. DOI: 10.1136/bmjopen-2017-017657. View

19.

Ho T, Huang C, Chiu H, Ruan S, Tsai Y, Yu C . Effectiveness of Telemonitoring in Patients with Chronic Obstructive Pulmonary Disease in Taiwan-A Randomized Controlled Trial. Sci Rep. 2016; 6:23797. PMC: 4814821. DOI: 10.1038/srep23797. View

20.

Yalcin A, Celik B, Yalcin A . Omalizumab (anti-IgE) therapy in the asthma-COPD overlap syndrome (ACOS) and its effects on circulating cytokine levels. Immunopharmacol Immunotoxicol. 2016; 38(3):253-6. DOI: 10.3109/08923973.2016.1173057. View